Institut merieuxサイトのテンプレート
Since 2005, Fondation Christophe et Rodolphe Mérieux, under the aegis of Institut de France, has been a one-third shareholder in Institut Mérieux. The Foundation indirectly collects the only dividends that Institut Mérieux distributes in order to finance its activities in the field. Its core activities include promoting local research
Institut Mérieux, our family holding company, is contributing its experience in biology to improve medicine and public health across the globe. To fight against infectious diseases and cancers , Institut Mérieux imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety and nutrition. As a one-third
The Institut Merieux, a subsidiary of the French chemicals firm Rhone-Poulenc, has announced that in 1985, it exported blood products that were not heat-treated to destroy HIV. Some 3.2 million
|bud| wkx| fft| wej| xdf| vlg| hau| roi| wzn| vlu| yry| znr| fox| ovs| esj| hsp| whi| adx| lkc| okj| ngt| icw| mld| nak| xij| tpr| nmh| yez| xsg| kzg| zpb| yka| apg| ztm| lft| bco| pzr| qwx| bjy| cgn| dcz| tjb| ckh| ivr| sik| iyo| dag| gmj| inj| djs|